Beijing SL Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
Complete Sustainability analysis of Beijing SL Pharmaceutical Co Ltd are accessed by logging in. This ESG rating includes seventeen UN SDGs including: 'No Poverty', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'. The SDG score for Beijing SL Pharmaceutical Co Ltd represents its transparency towards the UN SDGs.
Beijing SL Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Beijing SL Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Beijing SL Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Beijing SL Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Beijing SL Pharmaceutical Co Ltd report the average age of the workforce?
Does Beijing SL Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Beijing SL Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Beijing SL Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Beijing SL Pharmaceutical Co Ltd offer flexible work?
Does Beijing SL Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Beijing SL Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Beijing SL Pharmaceutical Co Ltd conduct supply chain audits?
Does Beijing SL Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Beijing SL Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Beijing SL Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Beijing SL Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Beijing SL Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Beijing SL Pharmaceutical Co Ltd disclose water use targets?
Does Beijing SL Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Beijing SL Pharmaceutical Co Ltd have a product recall in the last two years?
Does Beijing SL Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Beijing SL Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Beijing SL Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Beijing SL Pharmaceutical Co Ltd disclose parental leave metrics?
Does Beijing SL Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Beijing SL Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Beijing SL Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Beijing SL Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Beijing SL Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Beijing SL Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Beijing SL Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Beijing SL Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Beijing SL Pharmaceutical Co Ltd disclose its waste policy?
Does Beijing SL Pharmaceutical Co Ltd report according to TCFD requirements?
Does Beijing SL Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Beijing SL Pharmaceutical Co Ltd disclose energy use targets?
Does Beijing SL Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Beijing SL Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Beijing SL Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; ciclosporin; mycophenolate mofetil dispersible; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin (salmon); paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is based in Beijing, the People's Republic of China.